U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The order instructs the attorney general to move quickly toward reclassifying marijuana under the Controlled Substances Act, potentially shifting it from Schedule I to Schedule III.
If reclassified, marijuana would be grouped with drugs such as certain painkillers, ketamine, and testosterone, which are considered to have accepted medical uses and lower abuse potential. While marijuana would remain illegal at the federal level, the change could dramatically reshape the cannabis industry by expanding medical research opportunities, improving access to funding, and easing barriers for banks and institutional investors.
Trump defended the decision by emphasizing patient needs, saying many Americans suffering from chronic pain have pushed for greater access to marijuana-based treatments. Although he reiterated that he does not personally use the drug and remains cautious about controlled substances, he acknowledged its growing demand and medical relevance.
The move drew mixed reactions in Washington. Senate Democratic Leader Chuck Schumer welcomed the order, calling it a step toward long-overdue reform. In contrast, dozens of Republican lawmakers urged Trump not to proceed, arguing that reclassification could send the wrong message to children, empower drug cartels, and increase safety risks on U.S. roads.
Industry experts noted that congressional action would still be required to establish stable nationwide cannabis regulations. The Drug Enforcement Administration must now review the recommendation, a process that has historically been slowed by bureaucracy. Even with reclassification, marijuana would still face federal restrictions and criminal penalties.
Cannabis stocks initially rose on the news but later fell as investors realized the order did not include provisions for cannabis banking reform. Limited access to traditional financing remains a major challenge for marijuana companies, contributing to high operating costs and the persistence of black-market activity.
Public opinion continues to favor legalization, with most Americans supporting broader reform. Combined with previous efforts, including reviews initiated under former President Joe Biden, Trump’s order signals a continued shift toward easing long-standing federal marijuana policies while leaving the final outcome uncertain.


U.S. Justice Department Removes DHS Lawyer After Blunt Remarks in Minnesota Immigration Court
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms
Trump Threatens 50% Tariff on Canadian Aircraft Amid Escalating U.S.-Canada Trade Dispute
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
Faith Leaders Arrested on Capitol Hill During Protest Against Trump Immigration Policies and ICE Funding
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
ICE Blocked From Entering Ecuador Consulate in Minneapolis During Immigration Operation
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Extends AGOA Trade Program for Africa Through 2026, Supporting Jobs and U.S.-Africa Trade
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
U.S. Sanctions on Russia Could Expand as Ukraine Peace Talks Continue, Says Treasury Secretary Bessent
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
Trump Family Files $10 Billion Lawsuit Over IRS Tax Disclosure
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales 



